2012 Clinician Scientist Panel

Dr. Laurence Klotz, Chair
Clinical Uro-oncologist
Chief, Division of Urology 
Sunnybrook Health Sciences Centre
Toronto, ON

Dr. Armen G. Aprikian, Co-chair
Clinical Uro-oncologist
Head Division of Urology 
McGill University Health Centre 
Montreal General Hospital
Montreal, QC

Dr. Jeremy Squire
Research Chair in Molecular Pathology, Pathology & Molecular Medicine
Professor Pathology & Molecular Medicine, Pathology & Molecular Medicine
Director NCIC Clinical Trials Group, Cancer Biology & Genetics 
Queen's University 
Kingston, ON

Dr. Himansu (Himu) Lukka
Professor, Department of Oncology
Division of Radiation Oncology 
McMaster University 
Hamilton, ON

Dr. Danny Vesprini, Science Officer
Department of Radiation Oncology 
Sunnybrook Hospital
Toronto, ON

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.

Click here for news archive